Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Didanosine/hydroxycarbamide

Next Previous
Drug Profile

Didanosine/hydroxycarbamide

Alternative Names: ddI/HU - Virostatics; Didanosine/hydroxyurea - Virostatics; VS 411

Latest Information Update: 04 Mar 2011

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Virostatics
  • Class Antianaemics; Antineoplastics; Antiretrovirals; Dideoxynucleosides; Purine nucleosides; Ribonucleosides; Urea compounds
  • Mechanism of Action DNA synthesis inhibitors; Nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 02 Mar 2011 Discontinued - Phase-II for HIV-1 infections in Argentina, Uganda, Russia and Italy (PO)
  • 02 Mar 2011 Efficacy data from a phase II trial in HIV-1 infections released by Virostatics
  • 19 Jul 2010 Efficacy and adverse events data from a phase II trial in HIV-1 infections presented at the 18th International AIDS Conference (IAC-2010)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top